Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Industry in South Africa 2025" report has been added to ResearchAndMarkets.com's offering. This report on the pharmaceutical...
-
Jericho, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering...
-
Dublin, Sept. 12, 2025 (GLOBE NEWSWIRE) -- The "Coding & Marking Systems for Pharmaceutical Market - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. ...
-
Lakewood, CO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) (“KRTL Holding” or the “Company”) today announced that its wholly owned subsidiary, KRTL Biotech, Inc. (“KRTL...
-
Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The "Ireland Pharmaceuticals - Industry Report" report has been added to ResearchAndMarkets.com's offering.The analysis conducted in the Pharmaceuticals...
-
Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The "Counterfeit Drug Detection Device Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.The Global...
-
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates...
-
Median Overall Survival (OS) of 15 months for subjects with complete remission (n=8) Median OS of 2nd Line efficacy evaluable population of 12 months (n=9) Median OS of Intent to Treat population...
-
Jericho, New York, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and...
-
Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Jupiter...